| CAS: | 5966-29-0 | ||
| 分子式: | C34H69NO3 | ||
| 分子量: | 539.9166 | ||
| 英文名称: |
| ||
| 用途: | C16 dihydro Ceramide is a bioactive sphingolipid and precursor in the de novo synthesis of C16 ceramide (d18:0/16:0) that lacks the 4,5-trans double bond. |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||
| C912622 | MACKLIN | C16 dihydro Ceramide (d18:0/16:0) | 98% | 499元/1mg; 1389元/5mg; | 咨询 | ||||||||||||||||||||||
储存:-20°C,密闭,干燥 状态:白色固体 | |||||||||||||||||||||||||||
| 860634P | Avanti | C16 Dihydroceramide (d18:0/16:0) | Avanti Polar Lipids 860634P, powder | 1029.54元/5 MG; | 咨询 | ||||||||||||||||||||||
产品说明 应用 C16 Dihydroceramide (d18:0/16:0) is suitable for use to study the potential relevance of the changes observed in the sphingolipid composition of autophagosomes and autolysosomes in tetrahydrocannabinol (THC) treated cells or to destabilize biological membranes. 生化/生理作用 Dihydroceramide acts as a precursor for ceramide synthesis. It has an ability to induce autophagy in the perinuclear region. Dihydroceramide affects autophagic flux and enhances the formation lipid droplets. Accumulation of C16-dihydroceramides might lead to liver injury. 包装 5 mL Amber Glass Screw Cap Vial (860634P-10mg) 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||